The overall goal of this Program Project is to improve the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) in the treatment of hematological malignancies. We hope to achieve this goal by developing methods to improve the safety of the procedure, to increase its ability to eradicate malignancy, and to expand the application of transplantation to a broader population. Eight individual projects are proposed: 1. Nonmyeloablative Hematopoietic Stem Cell Allotransplants 2. Overcoming Genetic Barriers in Hematopoietic Stem Cell Transplantation 3. Induction of Immunological Tolerance after Hematopoietic Stem Cell Grafts 4. Pathophysiology and Prevention of Multi-organ Failure 5. Infectious Complications 6. Discovery and Validation of Genetic Markers of Prognosis and Residual Disease 7. Specific Adoptive Immunotherapy of Malignant Diseases 8. Minor Histocompatibility Antigens in Graft versus Leukemia Responses In addition, core support is requested in biostatistics, pathology, microbiology and virology, pharmacology, gastroenterology and pulmonary medicine, stem cell processing and storage, long-term follow-up, and administration. Our ability to successfully carry out the proposed work is greatly benefitted by: (1) the creation of a large group of investigators all focused on the general subject of HSCT; (2) the existence of strong preclinical research programs at our center in support of this topic; and (3) the accrual of 450-550 transplant patients onto research studies each year. Success in the achievement of our goal will not only benefit patients with hematological malignancies, but likely will have relevance for the use of intensive and immune based therapies to treat other malignant and nonmalignant diseases and for the care of the immunocompromised patient.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA018029-27
Application #
6420924
Study Section
Subcommittee G - Education (NCI)
Program Officer
Wu, Roy S
Project Start
1978-12-01
Project End
2006-11-30
Budget Start
2002-03-18
Budget End
2002-11-30
Support Year
27
Fiscal Year
2002
Total Cost
$6,361,387
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Salter, Alexander I; Pont, Margot J; Riddell, Stanley R (2018) Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131:2621-2629
Lee, Stephanie J; Nguyen, Tam D; Onstad, Lynn et al. (2018) Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:555-562
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Armenian, Saro H; Yang, Dongyun; Teh, Jennifer Berano et al. (2018) Prediction of cardiovascular disease among hematopoietic cell transplantation survivors. Blood Adv 2:1756-1764
Petersdorf, Effie W; Stevenson, Philip; Malkki, Mari et al. (2018) Patient HLA Germline Variation and Transplant Survivorship. J Clin Oncol 36:2524-2531
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580
Lee, Stephanie J; Onstad, Lynn; Chow, Eric J et al. (2018) Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica 103:1535-1541
McCune, Jeannine S; Storer, Barry; Thomas, Sushma et al. (2018) Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients. Biol Blood Marrow Transplant 24:1802-1807
Deegan, Anthony J; Talebi-Liasi, Faezeh; Song, Shaozhen et al. (2018) Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions. Lasers Surg Med 50:183-193
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515

Showing the most recent 10 out of 1845 publications